Jihong Ma, MD
Assistant Research Professor, Surgery-Plastic/Reconstructive
Publications
- CCR4-IL2 bispecific immunotoxin is more effective than brentuximab for targeted therapy of cutaneous T-cell lymphoma in a mouse CTCL model. Wang Z, Ma J, Zhang H, Ramakrishna R, Mintzlaff D, Mathes DW, Pomfret EA, Lucia MS, Gao D, Haverkos BM, Wang Z.
- Bivalent CD47 Immunotoxin for Targeted Therapy of T-Cell Acute Lymphoblastic Leukemia. Ma J et al. Blood. (2024)
- Toxicology, pharmacokinetics, and immunogenicity studies of CCR4-IL2 bispecific immunotoxin in rats and minipigs. Wang Z et al. Eur J Pharmacol. (2024)
Specialty Information
Specialties- Infectious Disease